Taken together, our study identify Raptin as a unique hypothalamic hormone that cooperates with GRM3 to suppress appetite and obesity, thus providing a potential new avenue to treat obesity. The gene discussed is GRM3; the disease is obesity due to melanocortin 4 receptor deficiency.